Clinical Study Results

• Terbogrel - Healthy

  Clinical Study Number	528.204
  Study Indication	Healthy
  Product	Terbogrel
  Generic Name	Terbogrel
  Lab Code
  Clinical Phase	I
  Study Title	Relative bioavailability and tolerability of two new different extended release capsules of 50 mg BIBV 308 SE each, versus a solution of 50 mg BIBV 308 SE administered orally twice a day for 3.5 days to healthy subjects (cross-over, open, randomised).
  Study Document	Trial synopsis 528.204 english

• Terbogrel - Healthy

  Clinical Study Number	528.22
  Study Indication	Healthy
  Product	Terbogrel
  Generic Name	Terbogrel
  Lab Code
  Clinical Phase	I
  Study Title	Relative bioavailability and tolerability of various experimental formulations of 50 mg BIBV 308 SE administered orally twice a day over 3.5 days to healthy subjects (intraindividual comparison, open, partially randomised).
  Study Document	Trial synopsis 528.22 english

• Terbogrel - Healthy

  Clinical Study Number	528.23
  Study Indication	Healthy
  Product	Terbogrel
  Generic Name	Terbogrel
  Lab Code
  Clinical Phase	I
  Study Title	Influence of oral doses of 75 mg Clopidogrel on the pharmacodynamics and safety of oral doses of 100 mg Terbogrel bid over 8 days in healthy male subjects. An intra-individual, open trial.
  Study Document	Trial synopsis 528.23_CO english